StonvexLoading…
StonvexStonvexStonvexCore line items from ANDE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $378.90M | $1.53B | $1.20B | $905.80M |
Operating Income | $33.89M | $141.47M | $53.89M | $28.05M |
Net Income | $33.19M | $95.71M | $28.28M | $8.14M |
EPS (Diluted) | $0.97 | $2.79 | $0.82 | $0.24 |
Total Assets | $3.92B | $3.71B | $3.30B | $3.45B |
Total Liabilities | $2.61B | $2.42B | $2.07B | $1.84B |
Cash & Equivalents | $72.40M | $98.28M | $81.63M | $350.97M |
Free Cash Flow OCF − CapEx | $-445.39M | $-56.13M | $20.97M | $-146.07M |
Shares Outstanding | 34.16M | 34.34M | 34.28M | 34.30M |